Literature DB >> 4146642

In-vivo measurements of tryptophan and tyrosine hydroxylase activities in mouse brain.

A Carlsson, M Lindqvist.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4146642     DOI： 10.1007/bf01244661

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


× No keyword cloud information.
  13 in total

1.  INHIBITION OF DECARBOXYLASE OF AROMATIC AMINO ACIDS BY 2,3,4-TRIHYDROXYBENZYLHYDRAZINE AND ITS SERYL DERIVATIVE.

Authors:  W P BURKARD; K F GEY; A PLETSCHER
Journal:  Arch Biochem Biophys       Date:  1964-08       Impact factor: 4.013

2.  A method for the fluorimetric determination of adrenaline and noradrenaline in tissues.

Authors:  A BERTLER; A CARLSSON; E ROSENGREN
Journal:  Acta Physiol Scand       Date:  1958-12-15

3.  The effect of L-tryptophan and some psychotropic drugs on the formation of 5-hydroxytryptophan in the mouse brain in vivo.

Authors:  A Carlsson; M Lindqvist
Journal:  J Neural Transm       Date:  1972       Impact factor: 3.575

4.  The determination of dopamine by a modification of the dihydroxyindole fluorimetric assay.

Authors:  C V Atack
Journal:  Br J Pharmacol       Date:  1973-08       Impact factor: 8.739

5.  Quantitative estimation of 5-hydroxy-3-indole acetic acid and 5-hydroxytryptophan in the brain following isolation by means of a strong cation exchange column.

Authors:  M Lindqvist
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1971

6.  Mechanism of release of alpha-methylated noradrenaline analogues by monoamine oxidase inhibitors.

Authors:  A Carlsson; M Lindqvist; B Waldeck
Journal:  Eur J Pharmacol       Date:  1968-04       Impact factor: 4.432

7.  Application of seady-state kinetics to studies of the transfer of 5-hydroxyindoleacetic acid from brain to plasma.

Authors:  N H Neef; T N Tozer; B B Brodie
Journal:  J Pharmacol Exp Ther       Date:  1967-11       Impact factor: 4.030

8.  Hallucinogenic drugs of the indolealkylamine type and central monoamine neurons.

Authors:  N E Andén; H Corrodi; K Fuxe
Journal:  J Pharmacol Exp Ther       Date:  1971-11       Impact factor: 4.030

9.  Lysergic acid diethylamide: sensitive neuronal units in the midbrain raphe.

Authors:  G K Aghajanian; W E Foote; M H Sheard
Journal:  Science       Date:  1968-08-16       Impact factor: 47.728

10.  A method for the determination of 3,4-dihydroxyphenylalanine (DOPA) in brain.

Authors:  W Kehr; A Carlsson; M Lindqvist
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000
View more
  28 in total

1.  Dopamine synthesis in the nigrostriatal system at the presymptomatic and early symptomatic stages in parkinsonian mice.

Authors:  G R Khakimova; E A Kozina; A Ya Sapronova; M V Ugrumov
Journal:  Dokl Biol Sci       Date:  2011-12-02

2.  The GABAB antagonist, CGP 35348, antagonizes the effects of baclofen, gamma-butyrolactone and HA 966 on rat striatal dopamine synthesis.

Authors:  P C Waldmeier
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-02       Impact factor: 3.000

3.  In vivo rates of tyrosine and tryptophan hydroxylation in regions of rat brain at four times during the light-dark cycle.

Authors:  J DiRaddo; C Kellogg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

4.  Effects of carbamazepine on dopamine function in rodents.

Authors:  M Elphick
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

5.  Comparison of diurnal and nocturnal rates of 5-hydroxytryptamine turnover in the rat mediobasal hypothalamus.

Authors:  T S King; S Steinlechner; R W Steger
Journal:  Experientia       Date:  1985-03-15

6.  Reversible Pharmacological Induction of Motor Symptoms in MPTP-Treated Mice at the Presymptomatic Stage of Parkinsonism: Potential Use for Early Diagnosis of Parkinson's Disease.

Authors:  Gulnara R Khakimova; Elena A Kozina; Valerian G Kucheryanu; Michael V Ugrumov
Journal:  Mol Neurobiol       Date:  2016-05-19       Impact factor: 5.590

7.  Day-night differences in estimated rates of 5-hydroxytryptamine turnover in the rat pineal gland.

Authors:  T S King; R W Steger; S Steinlechner; R J Reiter
Journal:  Exp Brain Res       Date:  1984       Impact factor: 1.972

8.  A comparison between the non-competitive NMDA antagonist dizocilpine (MK-801) and the competitive NMDA antagonist D-CPPene with regard to dopamine turnover and locomotor-stimulatory properties in mice.

Authors:  A Svensson; E Pileblad; M Carlsson
Journal:  J Neural Transm Gen Sect       Date:  1991

9.  Postmortem changes of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in mouse brain and their prevention by pargyline and microwave irradiation.

Authors:  M Van Wijk; J Korf
Journal:  Neurochem Res       Date:  1981-04       Impact factor: 3.996

10.  Chronic citalopram administration causes a sustained suppression of serotonin synthesis in the mouse forebrain.

Authors:  Gerard Honig; Minke E Jongsma; Marieke C G van der Hart; Laurence H Tecott
Journal:  PLoS One       Date:  2009-08-27       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.